Post New

Investor AB came up in this thread
https://www.shrewdm.com/MB?pid=148461170

There was some question about how U.S.-based people can access it, Investor AB can be accessed at Schwab via IVSXF (I checked in my account).

I did a quick "AI search" in Gemini using the following prompt. You can paste into the AI of your choice if interested in the firm.
"Do deep research on 'IVSXF' also known as Investor AB using publicly available information to assess its current, and past, financial health including but not limited to appropriate debt ratios (how leveraged?), and is it fairly or even undervalued today, and what is the appropriate metric to evaluate value of such a firm."

Have people here studied this firm in detail and willing to share some insights?

I calculated some performance metrics relative to SPY since 2010 (Yahoo data):

                                  IVSXF        SPY
Annualized Return              0.164          0.140
Annualized Std Dev             0.304          0.171
Annualized Sharpe (Rf=0%)      0.541          0.819
maxDrawdown                    0.439          0.3371

Some tidbits from the AI search (verify anything of interest):

- "Investor AB (IVSXF), the industrial holding company of the Wallenberg family, is often described as a 'proxy for the Swedish economy.' As of early 2026, the firm remains a bastion of financial stability ..."

- "The only appropriate metric to evaluate its value is Adjusted Net Asset Value (NAV)". Do you agree?

"Investor AB maintains an exceptionally conservative balance sheet, allowing it to act as a "lender of last resort" or a strategic buyer during market downturns"

"based on the Q4 2025 Year-End Report), Investor AB's portfolio is structured into three distinct pillars. To understand the "top holdings," you must look at the Listed Companies segment, which represents 72% of their total adjusted assets:

1) Listed companies

Company Est. Weight of Total Assets Sector
Atlas Copco ~14-16% Industrial Equipment
AstraZeneca ~11-13% Healthcare/Biopharma
ABB ~10-11% Electrification & Automation
SEB ~8-9%   Banking & Financials
Nasdaq, Inc.    ~5% Financial Technology/Exchanges
Sobi    ~4% Rare Disease Biopharma
Epiroc  ~4% Mining & Infrastructure
Ericsson    ~3-4%   Telecommunications

Looks like Atlas Copco (lots of industrial stuff, sold everywhere) and AstraZeneca (pharmaceuticals) account for 25%-30% of total assets.

2) Patricia Industrires (19% of portfolio)

3) EQT AB
"This segment provides a "high-growth kicker" to the portfolio, giving Investor AB exposure to thousands of private companies managed by EQT's private equity teams."

It seems quite interesting for those looking to diversify away from the U.S.

- "The only appropriate metric to evaluate its value is Adjusted Net Asset Value (NAV)". Do you agree?

I think a better approach would be more like the way I look at Berkshire.

* First, assure yourself that there isn't too much leverage or dumb management. If either of those is a concern, move to next company : )
* Divide the firm into investments, and everything else. (wholly owned operating subs, head office overhead, cost of debt, etc).
* Value investments at market value. If any big position seems plainly over or undervalued, do an adjustment on it, but not necessary most of the time.
* Value the rest based on a multiple of the net earnings on the rest, including all cost of debt etc.

Note that this does not subtract the debt; the thinking is that, having satisfied yourself at the first step that it's plainly at a safe level, the only thing that matters is its ongoing cost.

The reason for this preference is fairly straight forward: for operating divisions, especially for a group that likely has better than average economic characteristics, earning power value is probably better than net asset value.

I would put an asterisk on the characterization of "proxy for the Swedish economy". Yes, if you are interested in the Swedish economy and needed such a "one click" proxy, they're probably be the best. But if you're looking at a phrase that sums up the firm, that might not be sufficiently accurate, because they have a lot of non-Swedish things going on, especially in the listed portfolio. The subs are mostly closer to home.

Note, there are several US brokers that let you buy the shares on the Nasdaq Stockholm exchange.* Interactive Brokers, for one.

Jim

* Owned by Nasdaq Inc, so about 10% owned by Investor AB.

FYI, these articles are a good read for a primer on the firm. Probably not perfect, but certainly a lot of information collected in a single place.

First two from 2024:
Intro https://outsiderscorner.substack.com/p/investor-ab...
Part 2 https://outsiderscorner.substack.com/p/investor-ab...

Recent update on 2025 results:
https://outsiderscorner.substack.com/p/investor-ab...

Jim

Perfect, thank you!

Gemini (AI) Summary:

Investor AB (IVSBF/INVE-B) is Sweden's premier industrial holding company, often referred to as the "Berkshire Hathaway of the Nordics." Controlled by the Wallenberg family for over a century, the firm offers a unique blend of exposure to global blue-chip industrials, private equity, and venture capital.

Following the January 22, 2026, year-end earnings call, here is a comprehensive analysis of its viability as a long-term investment.

1. Business Model
Investor AB generates value through a three-pillar investment strategy:

Listed Companies (72% of Assets): Significant minority stakes in world-class Swedish giants including Atlas Copco, ABB, AstraZeneca, SEB, and Ericsson. Revenue is generated through dividends and long-term capital appreciation.

Patricia Industries (19% of Assets): A portfolio of wholly-owned, unlisted subsidiaries. Key holdings include Mölnlycke (medical solutions), Permobil (power wheelchairs), and the newly integrated Nova Biomedical.

Investments in EQT (9% of Assets): Ownership in EQT AB (the private equity firm) and limited partner investments in EQT funds. This provides exposure to high-growth, leveraged buyouts and infrastructure globally.

2. Financial Health (Last 3-5 Years)
Investor AB’s financial strategy is defined by low leverage and consistent dividend growth.

Net Asset Value (NAV) Growth: Adjusted NAV grew by 14% in 2025, reaching SEK 1,087 billion. The 5-year average total return (TSR) sits at a robust 19.4%, consistently outperforming the SIXRX benchmark.

Leverage (Net Debt/EBITDA): The company operates with very low leverage, ending 2025 at 2.1% (well within its <10% target). Interest coverage remains exceptionally high at over 42x.

Capital Allocation: Sound and disciplined. In 2025, they deployed SEK 29 billion into new investments, including increasing stakes in Ericsson and Atlas Copco during market dips, while raising the dividend by 8% to SEK 5.60.

3. Competitive Advantage
Investor’s "moat" is built on its Buy-and-Build philosophy and the Wallenberg Network.

The Network Moat: They provide portfolio companies with access to a global network of talent and industrial expertise that few competitors can match.

Pricing Power: Most of their listed holdings (Atlas Copco, AstraZeneca) possess "Wide Moat" status due to high switching costs and specialized technology.

vs. Competitors: Compared to Industrivärden (their closest Swedish rival), Investor AB is more diversified through its private equity arm (Patricia Industries). While Industrivärden focuses purely on listed Swedish large-caps, Investor’s unlisted portfolio provides a "valuation buffer" during public market volatility.

4. Growth Drivers & Industry Trends
The "MedTech" Pivot: Through Patricia Industries, Investor is aggressively expanding into healthcare. The acquisition of Nova Biomedical in 2025 is a key catalyst for 2026/2027 earnings growth.

AI and Automation: Their industrial holdings (ABB and Atlas Copco) are primary beneficiaries of the "Smart Factory" and AI-driven automation trends.

Headwinds: Global trade tensions and newly proposed tariffs (specifically targeting European exports to the US) remain a significant risk for their export-oriented industrial base.

5. Risks
Currency Volatility: As a Swedish company with global operations, a strengthening SEK significantly impacts the reported sales of Patricia Industries (which saw a -9% return in 2025 primarily due to FX).

Concentration Risk: The portfolio is heavily weighted toward a few key names (AstraZeneca and Atlas Copco). Any sector-specific downturn in Pharma or Industrial Capital Goods disproportionately affects NAV.

Regulatory Risk: Ongoing EU/US regulatory scrutiny on "dual-class" share structures (which the Wallenbergs use to maintain control) could theoretically impact valuation if governance rules tighten.

6. Valuation Context
Investor AB typically trades at a discount to its Net Asset Value (NAV).

Current Valuation: As of March 2026, the stock trades at approximately SEK 350, implying a ~12-15% discount to its adjusted NAV per share of SEK 355.

Multiples: Its forward P/E of ~7x and EV/EBITDA of 1.6x are historically low, reflecting the "holding company discount." However, compared to its 5-year median P/E of 4.6x, it currently looks slightly "expensive" on a pure earnings basis, though justified by the higher-quality private portfolio.

7. Bull/Bear Case (3-Year Outlook)
Bull Case (Target: SEK 500+)

Catalyst: A successful IPO of Mölnlycke or a major valuation step-up in EQT funds.

Scenario: Global interest rates stabilize, fueling a new M&A cycle for EQT. Patricia Industries achieves its 10% organic growth target, and the NAV discount narrows to <5% as international investors seek "Safe Haven" industrial quality.

Bear Case (Target: SEK 280-310)

Catalyst: Escalating global trade war and US-EU tariffs.

Scenario: A deep recession in the Eurozone and China hits Atlas Copco and ABB orders. The USD weakens significantly against the SEK, causing Patricia Industries' margins to contract. The NAV discount widens to 25% as risk-off sentiment prevails.

Final Assessment
Investor AB is a "Core Holding" candidate. It is a viable long-term investment for those seeking diversified industrial exposure with a built-in "active management" layer. Its resilience in 2025 despite FX headwinds suggests a robust floor for the stock.

This example clearly illustrates the dangers of AI: a collection of wonderfully structured arguments and conclusions that lull you into believing more and more of the nonsense that is ultimately claimed.
For example
"Investor AB typically trades at a discount to its Net Asset Value (NAV).
Current Valuation: As of March 2026, the stock trades at approximately SEK 350, implying a ~12-15% discount to its adjusted NAV per share of SEK 355."
First, NAV and adjusted NAV are equated and then a non-existent discount is calculated.
I didn't even bother to check the rest because the credibility of the statements had already been completely lost.

For those interested in Investor AB, this website calculates the NAV of Investor (and other Swedish investment firms) and compares the NAV (reported and calculated) historically with the stock market price. I haven't checked the numbers for accuracy.

Unfortunately, it's only available in Swedish, but translation programs can help.

https://ibindex.se/ibi/#/company/INVE%20B

Post New

US Policy FAQ

---

Contact Shrewd'm
Contact the developer of these message boards.